Literature DB >> 23128292

Tuberculosis and histoplasmosis co-infection in AIDS patients.

Carlos A Agudelo1, Carlos A Restrepo, Diego A Molina, Angela M Tobón, Carol A Kauffman, Carolina Murillo, Angela Restrepo.   

Abstract

Abstract. Coinfection with tuberculosis in some countries occurs in 8-15% of human immunodeficiency virus (HIV) -infected patients who have histoplasmosis. This coinfection interferes with prompt diagnosis, and treatment is difficult because of drug interactions. We retrospectively reviewed the cases of 14 HIV-infected patients who had concomitant tuberculosis and histoplasmosis. The most frequent clinical manifestations were weight loss (85.7%), asthenia (78.5%), and fever (64.2%). The diagnosis of histoplasmosis was made primarily by histopathology (71.4%), and the diagnosis of tuberculosis was made by means of direct microscopic examination (71.4%). Death occurred in two patients, and relapse of both infections occurred in one patient. Moxifloxacin was substituted for rifampicin in six patients, with good outcomes noted for both infections. The clinical presentation does not readily identify acquired immunodeficiency syndrome (AIDS) patients who have tuberculosis and histoplasmosis. The use of a fluoroquinolone as an alternative agent in place of rifampicin for tuberculosis allows effective therapy with itraconazole for histoplasmosis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23128292      PMCID: PMC3516081          DOI: 10.4269/ajtmh.2012.12-0292

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  25 in total

1.  Extrapulmonary tuberculosis masking disseminated histoplasmosis in AIDS.

Authors:  L Greene; B Peters; S B Lucas; A L Pozniak
Journal:  Sex Transm Infect       Date:  2000-02       Impact factor: 3.519

2.  Case definitions for public health surveillance.

Authors:  M Wharton; T L Chorba; R L Vogt; D L Morse; J W Buehler
Journal:  MMWR Recomm Rep       Date:  1990-10-19

3.  Serum ferritin levels correlate with disease activity in patients with AIDS and disseminated histoplasmosis.

Authors:  D H Kirn; D Fredericks; J A McCutchan; D Stites; M Shuman
Journal:  Clin Infect Dis       Date:  1995-10       Impact factor: 9.079

4.  Prospective study of histoplasmosis in patients infected with human immunodeficiency virus: incidence, risk factors, and pathophysiology.

Authors:  D S McKinsey; R A Spiegel; L Hutwagner; J Stanford; M R Driks; J Brewer; M R Gupta; D L Smith; M C O'Connor; L Dall
Journal:  Clin Infect Dis       Date:  1997-06       Impact factor: 9.079

5.  Coadministration of rifampin and itraconazole leads to undetectable levels of serum itraconazole.

Authors:  J Drayton; G Dickinson; M G Rinaldi
Journal:  Clin Infect Dis       Date:  1994-02       Impact factor: 9.079

Review 6.  Inducing properties of rifabutin, and effects on the pharmacokinetics and metabolism of concomitant drugs.

Authors:  M S Benedetti
Journal:  Pharmacol Res       Date:  1995-10       Impact factor: 7.658

7.  [Overview of the HIV/tuberculosis coinfection in Bogotá, Colombia, 2001].

Authors:  Ingrid García; Adriana Merchán; Pablo Enrique Chaparro; Lilia Edith López
Journal:  Biomedica       Date:  2004-06       Impact factor: 0.935

8.  Histoplasmosis: results of the Colombian national survey, 1992-2008.

Authors:  Myrtha Arango; Elizabeth Castañeda; Clara Inés Agudelo; Catalina De Bedout; Carlos Andrés Agudelo; Angela Tobón; Melva Linares; Yorlady Valencia; Angela Restrepo
Journal:  Biomedica       Date:  2011 Jul-Sep       Impact factor: 0.935

9.  Effect of rifampicin on the pharmacokinetics of itraconazole in normal volunteers and AIDS patients.

Authors:  S Jaruratanasirikul; S Sriwiriyajan
Journal:  Eur J Clin Pharmacol       Date:  1998-04       Impact factor: 2.953

10.  1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults.

Authors: 
Journal:  MMWR Recomm Rep       Date:  1992-12-18
View more
  15 in total

1.  High Mortality and Coinfection in a Prospective Cohort of Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome Patients with Histoplasmosis in Guatemala.

Authors:  Blanca Samayoa; Monika Roy; Angela Ahlquist Cleveland; Narda Medina; Dalia Lau-Bonilla; Christina M Scheel; Beatriz L Gomez; Tom Chiller; Eduardo Arathoon
Journal:  Am J Trop Med Hyg       Date:  2017-07       Impact factor: 2.345

2.  Clinical and Laboratory Profile of Persons Living with Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome and Histoplasmosis from a Colombian Hospital.

Authors:  Diego H Caceres; Angela M Tobón; Angela Ahlquist Cleveland; Christina M Scheel; Dedsy Y Berbesi; Jesús Ochoa; Angela Restrepo; Mary E Brandt; Tom Chiller; Beatriz L Gómez
Journal:  Am J Trop Med Hyg       Date:  2016-08-01       Impact factor: 2.345

3.  A multiplex real-time PCR assay for identification of Pneumocystis jirovecii, Histoplasma capsulatum, and Cryptococcus neoformans/Cryptococcus gattii in samples from AIDS patients with opportunistic pneumonia.

Authors:  Sara Gago; Cristina Esteban; Clara Valero; Oscar Zaragoza; Jorge Puig de la Bellacasa; María José Buitrago
Journal:  J Clin Microbiol       Date:  2014-01-29       Impact factor: 5.948

4.  Summary of Guidelines for Managing Histoplasmosis among People Living with HIV.

Authors:  Freddy Perez; Diego H Caceres; Nathan Ford; Giovanni Ravasi; Beatriz L Gomez; Alessandro C Pasqualotto; Paul Hine; Antoine A Adenis; Mathieu Nacher; Tom Chiller; John Baddley
Journal:  J Fungi (Basel)       Date:  2021-02-12

5.  Miliary tuberculosis in an Indian lady: Looking beyond miliary tuberculosis.

Authors:  Arjun Lakshman; Varun Dhir; Narender Kumar; Manphool Singhal
Journal:  Lung India       Date:  2015 Sep-Oct

6.  Challenges in the management of disseminated progressive histoplasmosis in human immunodeficiency virus-infected patients in resource-limited settings.

Authors:  Richard A Murphy; Lilishia Gounder; Thandekile C Manzini; Pratistadevi K Ramdial; Carmen Castilla; Mahomed-Yunus S Moosa
Journal:  Open Forum Infect Dis       Date:  2015-03-30       Impact factor: 3.835

7.  Histoplasmosis in HIV-Infected Persons, Yaoundé, Cameroon.

Authors:  Christine E Mandengue; Antoinette Ngandjio; Paul J A Atangana
Journal:  Emerg Infect Dis       Date:  2015-11       Impact factor: 6.883

8.  Disseminated histoplasmosis and tuberculosis: dual infection in a non-endemic region.

Authors:  Karuna Anot; Sanjana Sharma; Monica Gupta; Daljinderjit Kaur
Journal:  BMJ Case Rep       Date:  2020-08-24

Review 9.  Histoplasmosis in Africa: An emerging or a neglected disease?

Authors:  Rita O Oladele; Olusola O Ayanlowo; Malcolm D Richardson; David W Denning
Journal:  PLoS Negl Trop Dis       Date:  2018-01-18

10.  The important role of co-infections in patients with AIDS and progressive disseminated histoplasmosis (PDH): A cohort from Colombia.

Authors:  Diego H Caceres; Ángela M Tobón; Ángela Restrepo; Tom Chiller; Beatriz L Gómez
Journal:  Med Mycol Case Rep       Date:  2018-01-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.